UBS has downgraded Regeneron Pharmaceuticals Inc (NASDAQ:REGN) to "Neutral" from "Buy" given uncertainty around its key Eylea franchise. Brokerage slashed price target to $738 from $1130.

The U.S. Department of Labor granted UBS a waiver the Swiss bank needs to continue managing U.S. retirement plans after a ...

Stocks, bonds and the dollar saw small moves, with Treasury secretary nominee Scott Bessent appearing before Senate.

UBS analysts downgraded Cie de Saint-Gobain (SGO:FP) (OTC: CODYY) stock from Buy to Neutral, while slightly increasing the price target to EUR92.00 from EUR91.00. The revision follows a period of ...

UBS Group AG is asking investors to short India’s rupee and go underweight on the country’s stocks.

Over the past month, Indian stocks have seen nearly $500 billion wiped off their market value. This marks the worst start to ...

(Bloomberg Opinion) -- The big question for UBS Group AG shareholders is how badly its share buyback promises will be knocked ...

Eric Sim, formerly a managing director at UBS, said people working doggedly towards retirement without knowing what they'll ...

In Asia, the combined mega-bank is almost done with its data migration, while preparations have just begun in Switzerland. So ...

UBS Singapore sets a new record in the Singapore Book of Records with a 60-metre-long tapestry collectively woven together by UBS employees and community partners.

Swiss-based private bank Maerki Baumann is establishing a new business division for entrepreneurs, led by a former senior ...

In a report released on January 13, Richard Chamberlain from RBC Capital maintained a Buy rating on Marks and Spencer (MKS – Research Report), ...